RNA5SP413

Across TCGA pan-cancer cohorts, RNA5SP413 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated RNA5SP413 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RNA5SP413 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNA5SP413 expression acts as an unfavorable survival marker, although some lineages such as OV show a favorable association.

BLCA, STAD, and KIRC are the cancer types where RNA5SP413 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	III,IV	0.111	0.684	<.001	117	view →
STAD	DFS	Tertile	All	0.253	0.567	<.001	108	view →
KIRC	DFS	Tertile	III,IV	0.187	0.666	<.001	90	view →
UCS	OS	Tertile	II,III,IV	0.001	0.616	<.001	90	view →
LIHC	OS	Tertile	All	0.028	0.775	<.001	54	view →
HNSC	OS	Tertile	III,IV	0.305	0.666	.009	30	view →
TGCT	DFS	Tertile	All	0.035	0.837	<.001	18	view →
UCEC	DFS	Tertile	IV	0.194	0.726	<.001	18	view →
PCPG	DFS	Tertile	All	0.025	0.936	<.001	18	view →
OV	OS	Tertile	IV	0.669	0.338	.025	6	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

RNA5SP413–BLCA (OS)

Open the BLCA breakdown →